All in! on the news

Santé

Cession

Conseil des Vendeurs

DDA & Company represented Hyphen BioMed SAS on its sale to Sysmex Corporation DDA & Company represented the shareholders of Hyphen BioMed SAS, a scientific company boasting an extended experience in the field of Thrombosis, Haemostasis and Auto-Immunity providing a comprehensive offering of diagnostic and research reagents, distributed worldwide, on its sale to Japanese listed Sysmex Corporation

In 2010, Sysmex Corporation aquired HYPHEN BioMed enabling us to provide a comprehensive line of reagents to compliment our existing Siemens haemostasis reagents portfolio.

HYPHEN BioMed is a scientific company with experience in the field of thrombosis, haemostasis and auto-immunity, producing a full line of diagnostic and research reagents, distributed worldwide.